Plasma oxidative and inflammatory markers in patients with idiopathic Parkinson's disease

Acta Neurologica Belgica

Volumn 112, Issue 2, 2012, Pages 155-159

  Andican, Gülnur ^a   Konukoglu, Dildar ^a   Bozluolcay, Melda ^a   Bayülkem, Kemal ^a   Firtiına, Sinem ^a   Burcak, Gülden ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

hs CRP; l dopa; ox LDL; Parkinson; Soluble intracellular adhesion molecule

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LEVODOPA; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; IDIOPATHIC DISEASE; MALE; NERVOUS SYSTEM INFLAMMATION; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOGENESIS; PROTEIN BLOOD LEVEL;

EID: 84863594418     PISSN: 03009009     EISSN: 22402993     Source Type: Journal    
DOI: 10.1007/s13760-012-0015-3     Document Type: Article

References (22)

1. Hornykiewicz O, Kish SJ (1987) Biochemical pathophysiology of Parkinson's disease. Adv Neurol 45: 19-34.
2. Hirsch EC (1993) Does oxidative stress participate in nerve cell death in Parkinson's disease? Eur Neurol 33: 52-59.
3. Fahn S, Sulzer D (2004) Neurodegeneration and neuroprotection in Parkinson disease. NeuroRx. 1: 139-154.
4. Fahn S, Cohen G (1992) The oxidant stress hypothesis in Parkinson's disease. Evidence supporting it. Ann. Neurol. 32: 804-812.
5. Hunot S, Hirsch EC (2003) Neuroinflammatory processes in Parkinson's disease. Ann Neurol 53: S49-S58.
6. Hald A, Lotharius J (2005) Oxidative stress and inflammation in Parkinson's disease: is there a causal link? Exp Neurol 193: 279-290.
7. Mogi M, Harada M, Kondo T, Riederer P, Inagaki H et al (1994) Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. Neurosci Lett 180: 147-150.
8. Orr CF, Rowe DB, Halliday GM (2002) An inflammatory review of Parkinson's disease. Prog Neurobiol 68: 325-340.
9. Wu SS, Frucht SJ (2005) Treatment of Parkinson's disease: what's on the horizon? CNS Drugs 19(9): 723-743.
10. Allain H, Bentué-Ferrer D, Akwa Y (2008) Disease-modifying drugs and Parkinson's disease. Prog Neurobiol 84: 25-39.
11. Salvayre R, Auge N, Benoist H, Negre-Salvayre A (2002) Oxidized low-density lipoprotein-induced apoptosis. Biochim Biophys Acta 1585(2-3): 213-221.
12. Song IU, Chung SW, Kim JS, Lee KS (2011) Association between high-sensitivity C-reactive protein and risk of early idiopathic Parkinson's disease. Neurol Sci. 32(1): 31-34.
13. Miklossy J, Doudet DD, Schwab C, Yu S, McGeer EG, McGeer PL (2006) Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys. Exp Neurol 197(2): 275-283.
14. Szmitko PE, Wang CH, Weisel RD, Jeffries GA, Anderson TJ, Verma S (2003) Biomarkers of vascular disease linking inflammation to endothelial activation: Part II. Circulation 108: 2041-2048.
15. Inoue N (2006) Vascular C-reactive protein in the pathogenesis of coronary artery disease: role of vascular inflammation and oxidative stress. Cardiovasc Hematol Disord Drug Targets 6(4): 227-231.
16. Weber C, Fraemohs L, Dejana E (2007) The role of functional adhesion molecules in vascular inflammation. Nat Rev Immunol 7(6): 467-477.
17. McGeer PL, McGeer EG (2008) Glial reactions in Parkinson's disease. Mov Disord 23(4): 474-483.
18. Hermanowicz N (2007) Drug therapy for Parkinson's disease. Semin Neurol 27(2): 97-105.
19. Gao HM, Liu B, Zhang W, Hong JS (2003) Novel anti-inflammatory therapy for Parkinson's disease. Trends Pharmacol Sci 24(8): 395-401.
20. Hald A, Lotharius J (2005) Oxidative stress and inflammation in Parkinson's disease: is there a causal link? Exp Neurol 193: 279-290.
21. Wilms H, Zecca L, Rosenstiel P, Sievers J, Deuschl G, Lucius R (2007) Inflammation in Parkinson's diseases and other neurodegenerative diseases: cause and therapeutic implications. Curr Pharm Des 13(18): 1925-1928.
22. Schroeter H, Williams RJ, Versen L, Rice-Evans CA (2000) Phenolic antioxidants attenuate neuronal cell death following uptake of oxidized low-density lipoprotein. Free Radic Biol Med 29(12): 1222-1233.